Always pay close attention to new stock price targets from firms, like Needham.
While the firm won’t always get it right, price upgrades are still worth paying attention to.
Perhaps they’re seeing favorable industry trends that are impacting a covered stock. Maybe the financial health of a stock based on earnings or guidance is improving. Or, perhaps, they liked what they heard in a meeting with management.
Whatever the case, it’s a good idea to look into the reasoning for a price upgrade.
That being said, here’s what Needham analysts recently upgraded.
Boston Scientific (SYM: BSX)
Analysts at Needham just upgraded Boston Scientific to a buy rating with a $113 price target, noting that competition from pushed field ablation rivals is less intense then feared. In fact, according to the firm, BSX’s FARAPULSE is still the preferred option for ablation procedures.
The company also raised its full-year 2025 guidance.
As noted by Seeking Alpha, “Guidance for full-year 2025 organic growth was raised to 12%-14%, up from the previous 10%-12%. This adjustment reflects robust results across the cardiology portfolio and strong global execution.”
Recent earnings weren’t too shabby either. In its first quarter, EPS of 75 cents beat estimates by eight cents. Revenue of $4.66 billion, up 20.9% beat by $90 million.
Neurocrine Biosciences (SYM: NBIX)
Neurocrine Biosciences, a leading neuroscience-focused, biopharmaceutical company that helps develop life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders, was also upgraded to a buy rating.
Needham also has a price target of $138 on the NBIX stock.
Helping, Needham predicts that sales for Crenessity (used to treat congenital adrenal hyperplasia) will exceed the consensus by 8% to 10% for the year 2026 and beyond.
Analysts at RBC Capital also upgraded NBIX to an outperform rating, with a $138 price target. The firm believes NBIX offers an attractive entry point after a recent pullback.
Robinhood (SYM: HOOD)
Needham reiterated a buy rating on Robinhood with a $40 price target.
Not only has Bitcoin’s increased value boosted the HOOD stock, but so has its earnings. In its first quarter, HOOD’s EPS of 37 cents beat by four cents. Revenue of $927 million, up 50% year over year, beat by $9.84 million.
Transaction-based revenues increased 77% year-over-year to $583 million, primarily driven by cryptocurrencies revenue of $252 million, up 100%.
Even better, the company just authorized an additional $500 million in share repurchases. That follows a $1 billion share repurchase program announced in May 2024.
Further Reading: Confidential Economic Advisory
I’ve hesitated for months to record this video.
The very act of sharing these details makes me deeply uncomfortable. But recent events have forced my hand.
For over 40 years, I’ve operated at the highest levels of Wall Street. My investment firm has managed over $7 BILLION in assets. The New York Times and USA Today have documented my success, tracking everything from my luxury car collections to my private jets.
When the President is in residence at Mar-a-Lago — just a stone’s throw from my oceanfront estate — the Secret Service becomes part of our daily landscape. Tech visionaries, hedge fund titans, industrial magnates — these are the people I share dinner with.
I’m not sharing these details to boast. In fact, it pains me to speak so openly about my wealth.
But you need to understand something critical:
When someone like me — someone who has spent decades at the height of American wealth — is losing sleep over what’s coming, you should be deeply concerned.
What I’m witnessing is nothing short of an economic extinction event unfolding in real-time.
It’s more systemic, more fundamental, and far more dangerous than anything I’ve encountered in my 40 years on Wall Street.
Those with access to certain financial instruments will likely emerge even wealthier.
But for the average American? The outlook is grim.
I could remain silent, continue accumulating wealth, and watch from my oceanfront windows as millions of Americans are blindsided by what’s coming.
That would be the easy choice.
But I’ve reached a point in life where legacy matters more than additional zeros in my bank account.
The message you’re about to see will undoubtedly make me unpopular among my peers, many of whom are benefitting from this transition.
But the American public deserves to know what’s being orchestrated behind closed doors in Washington and on Wall Street.
I urge you to watch this immediately and take the actions I outline while there’s still time.
P.S. What lies ahead is far more severe than what we’ve already endured. The consequences will be devastating for unprepared Americans. Don’t be one of them.
